首页> 外文期刊>Cardiology >Statins, Ventricular Arrhythmias and Heart Rate Variability in Patients with Implantable Cardioverter Defibrillators and Coronary Heart Disease.
【24h】

Statins, Ventricular Arrhythmias and Heart Rate Variability in Patients with Implantable Cardioverter Defibrillators and Coronary Heart Disease.

机译:植入式心脏复律除颤器和冠心病患者的他汀类药物,室性心律失常和心率变异性。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to evaluate whether the incidence of ventricular arrhythmias and heart rate variability were influenced by statin treatment and lipid levels in patients treated with an implantable cardioverter defibrillator (ICD). Heart rate variability measurements were performed in 86 patients with coronary heart disease and an ICD implant. The number of events with ventricular fibrillation and ventricular tachycardia were recorded during a 12-month period. This study lends little support for an antiarrhythmic effect of statins or any relation between plasma lipids and lipoproteins and malignant ventricular arrhythmias in patients with an ICD. Copyright (c) 2005 S. Karger AG, Basel.
机译:这项研究的目的是评估在使用植入式心脏复律除颤器(ICD)治疗的患者中,他汀类药物治疗和血脂水平是否会影响室性心律失常的发生率和心率变异性。在86例患有冠心病和ICD植入物的患者中进行了心率变异性测量。在12个月内记录了发生室颤和室性心动过速的事件数。这项研究几乎没有支持他汀类药物的抗心律失常作用或血浆脂质和脂蛋白与ICD患者恶性室性心律失常之间的任何关系。版权所有(c)2005 S.Karger AG,巴塞尔。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号